OVID
NASDAQ
$2.41
Ovid Therapeutics Inc (OVID)
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $5.47 (+126.97%)
Market Cap
$416M
Free Cash Flow Yield
-10.07%
Beta (5Y)
1.42
Price Chart
Valuation
Market Cap$416M
Forward P/E1.79
P/S64.47
P/B2.30
Profitability
Total Revenue (TTM)$7.12M
Gross Profit (TTM)$7.12M
EBITDA-$48M
Operating Margin-679%
EPS-$0.14
Financial Health
Free Cash Flow Yield-10.07%
Growth & Risk
Revenue 5Y CAGR-49.69%
Beta (5Y)1.42
Sharpe Ratio1.83